International guidelines recommend positron emission computed tomography (PET/CT) with PSMA-ligands (e.g., [68Ga]Ga-PSMA-11), as the gold standard for the staging of high-risk PCa and for the diagnosis of biochemical recurrence (BCR). Here, FOLH1 is linked to posterior cortical atrophy.